Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alternative Treatment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04207216
What this trial is testing

Use of Alternative Therapy in Psoriasis Vulgaris Patients

Who this might be right for
Psoriasis Vulgaris
Istanbul Medeniyet University 1,618
Early research (Phase 1)Active Not RecruitingNCT03749187
What this trial is testing

BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas

Who this might be right for
GlioblastomaIDH1 Gene MutationIDH2 Gene Mutation+7 more
University of California, San Francisco 78
Testing effectiveness (Phase 2)Study completedNCT02093533
What this trial is testing

Eculizumab in Primary MPGN

Who this might be right for
Membranoproliferative Glomerulonephritis
Mario Negri Institute for Pharmacological Research 10
Testing effectiveness (Phase 2)Study completedNCT01565538
What this trial is testing

Erlotinib Versus Pemetrexed as Second-Line Therapy in Treating Patients With Advanced Lung Adenocarcinoma

Who this might be right for
Lung Cancer
Si-Yu Wang 123
Not applicableStudy completedNCT00860548
What this trial is testing

SCOT Scleroderma Treatment Alternative Registry (STAR Registry)

Who this might be right for
Scleroderma, SystemicSclerosis
National Institute of Allergy and Infectious Diseases (NIAID) 19
Not applicableStudy completedNCT01430208
What this trial is testing

A New Alternative to Traditional Hysteroscopy

Who this might be right for
Intrauterine DiseasesMyomasPolyps
Catholic University of the Sacred Heart 401
Testing effectiveness (Phase 2)Looking for participantsNCT03683433
What this trial is testing

Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene Mutation

Who this might be right for
Acute Bilineal LeukemiaAcute Biphenotypic LeukemiaChronic Myelomonocytic Leukemia+4 more
M.D. Anderson Cancer Center 50
Not applicableStudy completedNCT07565142
What this trial is testing

Medical Effects of Proximal (In-person) Intercessory (PIP) and Virtual Intercessory Prayer (VIP) on Pain and Anxiety

Who this might be right for
Pain and AnxietyComplementary Therapies
University of Maryland, Baltimore 180
Testing effectiveness (Phase 2)Study completedNCT00094445
What this trial is testing

Trial of Curcumin in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic NeoplasmsAdenocarcinoma
M.D. Anderson Cancer Center 50
Post-approval studies (Phase 4)Ended earlyNCT05183828
What this trial is testing

Effect of HSD3B1 (1245C) Gene Mutation on Treatment of Stage I-III Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+2 more
University of Washington 62
Not applicableStudy completedNCT01363596
What this trial is testing

International NaProTechnology Evaluation and Surveillance of Treatment for Infertility and Miscarriage (iNEST)

Who this might be right for
InfertilityMiscarriage
University of Utah 834
Not applicableStudy completedNCT04538729
What this trial is testing

Use of Alternative Therapy in Acne Vulgaris Patients

Who this might be right for
Acne Vulgaris
Istanbul Medeniyet University 1,571
Testing effectiveness (Phase 2)Study completedNCT03845270
What this trial is testing

Her2-positive Lung Cancer Treated With Dedicated Drug

Who this might be right for
Non Small Cell Lung Cancer MetastaticNon Small Cell Lung Cancer Stage IIIHER2 Gene Mutation
Intergroupe Francophone de Cancerologie Thoracique 46
Testing effectiveness (Phase 2)Study completedNCT02282345
What this trial is testing

Talazoparib Before Standard Therapy in Treating Patients With Invasive, BRCA-Mutated Breast Cancer

Who this might be right for
Breast AdenocarcinomaDeleterious BRCA1 Gene MutationDeleterious BRCA2 Gene Mutation+2 more
M.D. Anderson Cancer Center 36
Testing effectiveness (Phase 2)Ended earlyNCT01555489
What this trial is testing

Assessing the Efficacy and Safety of IV Vitamin C in Combination With Standard Chemotherapy for Pancreatic Ca

Who this might be right for
Stage IV Pancreatic Cancer
Thomas Jefferson University 11
Post-approval studies (Phase 4)Looking for participantsNCT05525338
What this trial is testing

Comparison of Standard Dose Alectinib to Alectinib in Adjusted Dose Based on Alectinib Bloodlevels

Who this might be right for
Drug MonitoringCarcinoma, Non-Small-Cell LungLung Cancer+2 more
University Medical Center Groningen 196
Testing effectiveness (Phase 2)Ended earlyNCT03459443
What this trial is testing

A Proof of Concept Study for a 12 Month Treatment in Patients With C3G or IC-MPGN Treated With ACH-0144471

Who this might be right for
C3 GlomerulonephritisC3 GlomerulopathyImmune Complex Membranoproliferative Glomerulonephritis+2 more
Alexion Pharmaceuticals, Inc. 22
Testing effectiveness (Phase 2)Study completedNCT00033852
What this trial is testing

Treatment of Depression With Massage in HIV

Who this might be right for
Acquired Immunodeficiency SyndromeHIV InfectionsDepression
National Center for Complementary and Integrative Health (NCCIH) 90
Testing effectiveness (Phase 2)Study completedNCT00034021
What this trial is testing

Ginkgo Biloba: Antidepressant-Induced Sexual Dysfunction

Who this might be right for
Hypoactive Sexual Desire DisorderSexual Dysfunctions, Psychological
National Center for Complementary and Integrative Health (NCCIH)
Testing effectiveness (Phase 2)UnknownNCT04324476
What this trial is testing

Bevacizumab Plus XELOX/XELIRI for First-line Treatment in Unresectable Advanced Colorectal Cancer

Who this might be right for
Advanced Colorectal Cancer
Jiangsu Cancer Institute & Hospital 50
Next Page